[Remote] Associate Director, Regional Marketing – South at Axsome Therapeutics Inc

Remote

Apply Now

Not SpecifiedCompensation

N/AExperience Level

N/AJob Type

Not SpecifiedVisa

N/AIndustries

Requirements

Bachelor's degree in a relevant field (marketing, life sciences, etc.)
5+ years of experience in pharmaceutical or biotechnology marketing, with a focus on regional or national roles
Proven track record of building and maintaining relationships with key external experts (KEEs)
Strong understanding of the immunological disease space, particularly IgA nephropathy (IgAN)
Experience with commercial-led advisory boards and other third-party insight gathering tactics
Strong analytical and problem-solving skills, with ability to collect, analyze, and synthesize information from diverse sources
Excellent communication and interpersonal skills, with ability to build and maintain relationships with KEEs, customers, and internal partners
Ability to work in a fast-paced environment and prioritize multiple projects and responsibilities

Responsibilities

Inform brand strategy through insights gathered from field-based KEE engagements and advisory boards
Solicit disease state and brand insights through 1:1 KEE engagements and gather and share these insights with internal partners
Organize and moderate regional and national advisory boards to understand customer and patient perspective
Actively collect, analyze, and synthesize information on KEE sentiments, competitor activities, and broader market trends
Aid in the development and execution of commercial-led advisory boards and other third-party insight gathering tactics
Track KEE beliefs over time on Vera, the IgAN treatment landscape, unmet clinical needs, and patient management
Create and execute an objective-based KEE advocacy building plan to include the identification and curation of relationships with established and emerging KEEs
Cultivate and develop KEEs over time who are experts in IgAN
Act as the face of Vera's commercial organization and drive impact through personalized 1:1 interactions and focused small group meetings
Identify, recruit, and train members of Vera's inaugural US Speaker Bureau
Develop and execute comprehensive Congress plans to include international, national, and regional conferences
Support the educational effectiveness of KEEs through engagement and collaboration on Vera's US Speaker Bureau

Axsome Therapeutics Inc

Develops therapies for CNS disorders

About Axsome Therapeutics Inc

Axsome Therapeutics develops therapies for central nervous system (CNS) disorders, focusing on conditions like major depressive disorder, treatment-resistant depression, and Alzheimer's agitation. Their main product, AXS-05, is an oral medication that works by blocking NMDA receptors in the brain, which helps regulate mood. This drug has shown positive results in clinical trials and has received special FDA status to speed up its approval process. Unlike many competitors, Axsome emphasizes addressing unmet medical needs in CNS disorders and aims to improve patient outcomes through rigorous research and development. The company's goal is to bring effective treatments to market, enhancing the quality of life for patients suffering from these conditions.

New York City, New YorkHeadquarters

2012Year Founded

$430.7MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

201-500Employees

Benefits

Performance Bonus

Company Equity

Risks

Increased competition from companies like Compass Pathways in the CNS market.

Potential delays in AXS-07 launch amid growing market anticipation.

Departure of key personnel like Lori Englebert may impact strategic direction.

Differentiation

Axsome focuses on CNS disorders with limited current treatment options.

AXS-05, an NMDA receptor antagonist, targets major depressive disorder and treatment-resistant depression.

Axsome's balanced portfolio includes both clinical and research stage products.

Upsides

FDA's fast-tracking of CNS treatments could expedite Axsome's drug approvals.

Increased investment in CNS R&D drives innovation, benefiting Axsome's pipeline.

Growing personalized medicine trend offers Axsome opportunities for tailored therapies.

Land your dream remote job 3x faster with AI

Try Jobo Free